In Vivo Bone Tissue Engineering Strategies: Advances and Prospects

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Critical-sized bone defects pose significant surgical challenges, with current repair methods having limitations such as graft resorption and donor-site morbidity.
• Bone tissue engineering (BTE) offers a novel approach but faces hurdles including insufficient vascularization and controversial scaffold/growth factor efficacy.
• The in vivo bioreactor principle (IVB) emerges as a promising strategy for predictable, patient-specific bone regeneration.

Purpose of the Study:

• To review the current limitations in bone defect repair and the potential of bone tissue engineering (BTE).
• To highlight the in vivo bioreactor principle (IVB) as a novel strategy for guided bone regeneration.
• To discuss the experimental evidence and future directions for IVB in clinical application.

Main Methods:

• Review of experimental studies on in vivo BTE strategies.
• Analysis of the in vivo bioreactor principle (IVB) concept, combining flap prefabrication and axial vascularization.
• Evaluation of challenges in BTE, including vascularization, scaffold, and growth factor administration.

Main Results:

• Current bone defect repair methods have significant drawbacks.
• In vivo BTE strategies, particularly the IVB concept, show efficacy in experimental studies.
• Insufficient vascularization remains a critical limitation for engineered bone constructs.

Conclusions:

• The in vivo bioreactor principle (IVB) presents a promising future direction for bone tissue engineering (BTE).
• Further research is required to overcome limitations for routine clinical application of IVB.
• IVB leverages the body's self-regenerative capacity for predictable, patient-specific bone regeneration.